Personalised medicine for nonsmall cell lung cancer

被引：34
|
作者：
Mascaux, Celine [1 ,2 ]
Tomasini, Pascale [1 ,2 ]
Greillier, Laurent [1 ,2 ]
Barlesi, Fabrice [1 ,2 ]
机构：
[1] Aix Marseille Univ, AP HM, Multidisciplinary Oncol & Therapeut Innovat Dept, Marseille, France
[2] Aix Marseille Univ, Inserm U911 CRO2, Marseille, France
来源：
EUROPEAN RESPIRATORY REVIEW | 2017年 / 26卷 / 146期
关键词：
PHASE-III TRIAL; CISPLATIN PLUS GEMCITABINE; OPEN-LABEL; 1ST-LINE TREATMENT; DOUBLE-BLIND; PD-L1; IMMUNOHISTOCHEMISTRY; MAINTENANCE THERAPY; MET AMPLIFICATION; AMERICAN-SOCIETY; PEMETREXED PLUS;
D O I：
10.1183/16000617.0066-2017
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
After years of standard care prescribed to cancer patients without any selection except the primary site and histology of the tumour, the era of precision medicine has revolutionised cancer care. Personalised medicine refers to the selection of patients for specific treatment based on the presence of specific biomarkers which indicate sensitivity to corresponding targeted therapies and/or lower toxicity risk, such that patients will have the greatest chance of deriving benefit from the treatments. Here, we review personalised medicine for nonsmall cell lung cancer.
引用
收藏
页数：13
相关论文
共 50 条
  • [21] GEMCITABINE IN NONSMALL CELL LUNG-CANCER
    SORENSEN, JB
    LUNG CANCER, 1995, 12 : S173 - S175
  • [22] Targeted therapy in nonsmall cell lung cancer
    Puri, T.
    INDIAN JOURNAL OF CANCER, 2017, 54 (01) : 83 - 88
  • [23] Nonsmall cell lung cancer in never smokers
    Scagliotti, Giorgio V.
    Longo, Marina
    Novello, Silvia
    CURRENT OPINION IN ONCOLOGY, 2009, 21 (02) : 99 - 104
  • [24] Perioperative immunotherapy for nonsmall cell lung cancer
    Huang, Jingya
    Li, Wenyuan
    Guo, Hui
    CURRENT OPINION IN ONCOLOGY, 2025, 37 (01) : 63 - 72
  • [25] Chemoradiation therapy in nonsmall cell lung cancer
    Baas, Paul
    Belderbos, Jose S. A.
    van den Heuvel, Michel
    CURRENT OPINION IN ONCOLOGY, 2011, 23 (02) : 140 - 149
  • [26] Perioperative immunotherapy in nonsmall cell lung cancer
    Zhang, Renzhi
    Zou, Chun
    Zeng, Liang
    Zhang, Yongchang
    CURRENT OPINION IN ONCOLOGY, 2025, 37 (01) : 40 - 47
  • [27] Personalized medicine in the treatment of advanced nonsmall cell lung cancer: step-by-step progress
    Gridelli, Cesare
    CURRENT OPINION IN ONCOLOGY, 2012, 24 (02) : 115 - 116
  • [28] Personalised cancer medicine
    Jackson, Sarah E.
    Chester, John D.
    INTERNATIONAL JOURNAL OF CANCER, 2015, 137 (02) : 262 - 266
  • [29] Bronchoscopic treatment of inoperable nonsmall cell lung cancer
    Kniese, Christopher M.
    Musani, Ali, I
    EUROPEAN RESPIRATORY REVIEW, 2020, 29 (158): : 1 - 10
  • [30] Thyroid Metastasis from Nonsmall Cell Lung Cancer
    Namad, Tariq
    Wang, Jiang
    Shipley, Ralph
    Karim, Nagla Abdel
    CASE REPORTS IN ONCOLOGICAL MEDICINE, 2013, 2013
12345